SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Abhishek Lenka, Shantala Hegde, Ketan Ramakant Jhunjhunwala, Pramod Kumar Pal, Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson's disease: A review, Parkinsonism & Related Disorders, 2016, 22, 1

    CrossRef

  2. 2
    Javier Pagonabarraga, Saul Martinez-Horta, Ramón Fernández de Bobadilla, Jesús Pérez, Roser Ribosa-Nogué, Juan Marín, Berta Pascual-Sedano, Carmen García, Alexandre Gironell, Jaime Kulisevsky, Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase, Movement Disorders, 2016, 31, 1
  3. 3
    Eun Joo Chung, Kyngha Seok, Sang Jin Kim, A comparison of Montreal Cognitive Assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease, Clinical Neurology and Neurosurgery, 2015, 130, 98

    CrossRef

  4. 4
    Chao-Yu Hsu, Ching-Sui Hung, Hung-Ming Chang, Wen-Chieh Liao, Shih-Chun Ho, Ying-Jui Ho, Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia, Neuropharmacology, 2015, 91, 43

    CrossRef

  5. 5
    James Gratwicke, Marjan Jahanshahi, Thomas Foltynie, Parkinson’s disease dementia: a neural networks perspective, Brain, 2015, 138, 6, 1454

    CrossRef

  6. 6
    James M. Shine, Joanna M.Z. Mills, Jessica Qiu, Claire O'Callaghan, Zoe Terpening, Glenda M. Halliday, Sharon L. Naismith, Simon J.G. Lewis, Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease, Movement Disorders Clinical Practice, 2015, 2, 2
  7. 7
    Lorenzo Kiferle, Roberto Ceravolo, Martina Giuntini, Giuseppe Linsalata, Giulia Puccini, Duccio Volterrani, Ubaldo Bonuccelli, Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study, Parkinsonism & Related Disorders, 2014, 20, 7, 761

    CrossRef

  8. 8
    Stewart A. Factor, Michael K. Scullin, Ann B. Sollinger, Julia O. Land, Cathy Wood-Siverio, Lavezza Zanders, Alan Freeman, Donald L. Bliwise, William M. McDonald, Felicia C. Goldstein, Cognitive correlates of hallucinations and delusions in Parkinson's disease, Journal of the Neurological Sciences, 2014, 347, 1-2, 316

    CrossRef

  9. 9
    Ahmed A. Moustafa, Rakhee Krishna, Michael J. Frank, Abeer M. Eissa, Doaa H. Hewedi, Cognitive correlates of psychosis in patients with Parkinson's disease, Cognitive Neuropsychiatry, 2014, 19, 5, 381

    CrossRef

  10. 10
    Shih-Chun Ho, Chih-Chuan Hsu, Cornelius Rainer Pawlak, Maria A. Tikhonova, Te-Jen Lai, Tamara G. Amstislavskaya, Ying-Jui Ho, Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model, Behavioural Brain Research, 2014, 268, 177

    CrossRef

  11. 11
    Dag Aarsland, John-Paul Taylor, Daniel Weintraub, Psychiatric issues in cognitive impairment, Movement Disorders, 2014, 29, 5
  12. 12
    Jennifer G. Goldman, Samantha Holden, Treatment of Psychosis and Dementia in Parkinson’s Disease, Current Treatment Options in Neurology, 2014, 16, 3

    CrossRef

  13. 13
    James M. Shine, Claire O’Callaghan, Glenda M. Halliday, Simon J.G. Lewis, Tricks of the mind: Visual hallucinations as disorders of attention, Progress in Neurobiology, 2014, 116, 58

    CrossRef

  14. 14
    Daniel Collerton, John-Paul Taylor, Advances in the treatment of visual hallucinations in neurodegenerative diseases, Future Neurology, 2013, 8, 4, 433

    CrossRef

  15. 15
    S. M. Makin, J. Redman, U. P. Mosimann, R. Dudley, M. P. Clarke, C. Colbourn, D. Collerton, Complex visual hallucinations and attentional performance in eye disease and dementia: a test of the Perception and Attention Deficit model, International Journal of Geriatric Psychiatry, 2013, 28, 12
  16. 16
    Joana B. Pereira, Carme Junqué, David Bartrés-Faz, Blanca Ramírez-Ruiz, Maria-Jose Marti, Eduardo Tolosa, Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease, Hippocampus, 2013, 23, 8
  17. 17
    Hee Kyung Park, Jae Seung Kim, Ki Chun Im, Mi Jung Kim, Jae-Hong Lee, Myoung C. Lee, Juhan Kim, Sun Ju Chung, Visual Hallucinations and Cognitive Impairment in Parkinson's Disease, The Canadian Journal of Neurological Sciences, 2013, 40, 05, 657

    CrossRef

  18. 18
    Ming-Hong Hsieh, Shih-Chun Ho, Kuei-Ying Yeh, Cornelius Rainer Pawlak, Hung-Ming Chang, Ying-Jui Ho, Te-Jen Lai, Fu-Ying Wu, Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model, Pharmacology Biochemistry and Behavior, 2012, 102, 1, 64

    CrossRef

  19. 19
    Ming-Hong Hsieh, Siao-Lin Gu, Shih-Chun Ho, Cornelius Rainer Pawlak, Chih-Li Lin, Ying-Jui Ho, Te-Jen Lai, Fu-Ying Wu, Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model, Behavioural Brain Research, 2012, 229, 1, 41

    CrossRef

  20. You have free access to this content20
    Lothar Burghaus, Carsten Eggers, Lars Timmermann, Gereon R. Fink, Nico J. Diederich, Hallucinations in Neurodegenerative Diseases, CNS Neuroscience & Therapeutics, 2012, 18, 2
  21. 21
    Naroa Ibarretxe-Bilbao, Carme Junque, Maria J. Marti, Eduardo Tolosa, Cerebral basis of visual hallucinations in Parkinson's disease: Structural and functional MRI studies, Journal of the Neurological Sciences, 2011, 310, 1-2, 79

    CrossRef

  22. 22
    Kolbjorn Bronnick, Murat Emre, Sibel Tekin, Siri B. Haugen, Dag Aarsland, Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease, Movement Disorders, 2011, 26, 5
  23. 23
    Daniel Collerton, Elaine Perry, Dreaming and hallucinations – Continuity or discontinuity? Perspectives from dementia with Lewy bodies, Consciousness and Cognition, 2011, 20, 4, 1016

    CrossRef

  24. 24
    Jennifer G. Goldman, New Thoughts on Thought Disorders in Parkinson's Disease: Review of Current Research Strategies and Challenges, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  25. 25
    G Graham, J Dean, UP Mosimann, C Colbourn, R Dudley, M Clarke, D Collerton, Specific attentional impairments and complex visual hallucinations in eye disease, International Journal of Geriatric Psychiatry, 2011, 26, 3
  26. 26
    D. A. Gallagher, L. Parkkinen, S. S. O'Sullivan, A. Spratt, A. Shah, C. C. Davey, F. D. Bremner, T. Revesz, D. R. Williams, A. J. Lees, A. Schrag, Testing an aetiological model of visual hallucinations in Parkinson's disease, Brain, 2011, 134, 11, 3299

    CrossRef

  27. 27
    Hiu-Ngar Sy, Shey-Lin Wu, Wen-Fu Wang, Chang-Hao Chen, Yao-Ting Huang, Ying-Ming Liou, Chien-Shun Chiou, Cornelius Rainer Pawlak, Ying-Jui Ho, MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus, Pharmacology Biochemistry and Behavior, 2010, 95, 2, 158

    CrossRef

  28. 28
    Gisela Llebaria, Javier Pagonabarraga, Mercè Martínez-Corral, Carmen García-Sánchez, Berta Pascual-Sedano, Alexandre Gironell, Jaime Kulisevsky, Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease, Movement Disorders, 2010, 25, 16
  29. 29
    Jim Barnes, Vince Connelly, Luci Wiggs, Laura Boubert, Ksenija Maravic, Sleep Patterns in Parkinson's Disease Patients with Visual Hallucinations, International Journal of Neuroscience, 2010, 120, 8, 564

    CrossRef

  30. 30
    Javier Rodríguez-Ferreiro, Manuel Menéndez, Renée Ribacoba, Fernando Cuetos, Action naming is impaired in Parkinson disease patients, Neuropsychologia, 2009, 47, 14, 3271

    CrossRef

  31. 31
    Yaroslau Compta, María J. Martí, Naroa Ibarretxe-Bilbao, Carme Junqué, Francesc Valldeoriola, Esteban Muñoz, Mario Ezquerra, Jose Ríos, Eduardo Tolosa, Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease, Movement Disorders, 2009, 24, 15
  32. 32
    Inga Liepelt, Matthias Reimold, Walter Maetzler, Jana Godau, Gerald Reischl, Alexandra Gaenslen, Heinz Herbst, Daniela Berg, Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG-PET, Movement Disorders, 2009, 24, 10
  33. 33
    Mitsuru Kawamura, Mutsutaka Kobayakawa, Emotional impairment in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S47

    CrossRef

  34. 34
    Nico J. Diederich, Gilles Fénelon, Glenn Stebbins, Christopher G. Goetz, Hallucinations in Parkinson disease, Nature Reviews Neurology, 2009, 5, 6, 331

    CrossRef

  35. 35
    A. M. Meppelink, B. M. de Jong, R. Renken, K. L. Leenders, F. W. Cornelissen, T. van Laar, Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations, Brain, 2009, 132, 11, 2980

    CrossRef

  36. 36
    Naroa Ibarretxe-Bilbao, Eduardo Tolosa, Carme Junque, Maria-Jose Marti, MRI and cognitive impairment in Parkinson's disease, Movement Disorders, 2009, 24, S2
  37. 37
    Joana B. Pereira, Carme Junqué, María-Jośe Martí, Blanca Ramirez-Ruiz, Nuria Bargalló, Eduardo Tolosa, Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease, Movement Disorders, 2009, 24, 8
  38. 38
    Joana B. Pereira, Carme Junqué, Maria J. Martí, Blanca Ramirez-Ruiz, David Bartrés-Faz, Eduard Tolosa, Structural brain correlates of verbal fluency in Parkinsonʼs disease, NeuroReport, 2009, 20, 8, 741

    CrossRef

  39. 39
    Blanca Ramírez-Ruiz, María-José Martí, Eduardo Tolosa, Carlos Falcón, Nuria Bargalló, Francesc Valldeoriola, Carme Junqué, Brain response to complex visual stimuli in Parkinson's patients with hallucinations: A functional magnetic resonance imaging study, Movement Disorders, 2008, 23, 16
  40. 40
    Mutsutaka Kobayakawa, Shinichi Koyama, Masaru Mimura, Mitsuru Kawamura, Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task, Movement Disorders, 2008, 23, 4
  41. 41
    N. Ibarretxe-Bilbao, B. Ramírez-Ruiz, E. Tolosa, M. J. Martí, F. Valldeoriola, N. Bargalló, C. Junqué, Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia, Journal of Neurology, 2008, 255, 9, 1324

    CrossRef

  42. 42
    Elena Sinforiani, Claudio Pacchetti, Roberta Zangaglia, Chiara Pasotti, Raffaele Manni, Giuseppe Nappi, REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: A two-year follow up, Movement Disorders, 2008, 23, 10
  43. 43
    Anne Marthe Meppelink, Janneke Koerts, Maarten Borg, Klaus Leonard Leenders, Teus van Laar, Visual object recognition and attention in Parkinson's disease patients with visual hallucinations, Movement Disorders, 2008, 23, 13
  44. 44
    Gabriella Santangelo, Luigi Trojano, Carmine Vitale, Marta Ianniciello, Marianna Amboni, Dario Grossi, Paolo Barone, A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations, Movement Disorders, 2007, 22, 16
  45. 45
    B. Ramírez-Ruiz, M.-J. Martí, E. Tolosa, M. Giménez, N. Bargalló, F. Valldeoriola, C. Junqué, Cerebral atrophy in Parkinson's disease patients with visual hallucinations, European Journal of Neurology, 2007, 14, 7
  46. 46
    Simon J.G. Lewis, James M. Shine, Daniel Brooks, Glenda M. Halliday, Hallucinogenic mechanisms: pathological and pharmacological insights,
  47. 47
    Jim Barnes, Neuropsychological approaches to understanding visual hallucinations,